N S Turhal

Summary

Affiliation: Istanbul University
Country: Turkey

Publications

  1. ncbi Results of paclitaxel (day 1 and 8) and carboplatin given on every three weeks in advanced (stage III-IV) non-small cell lung cancer
    Perran F Yumuk
    Division of Medical Oncology, Marmara University Hospital, Tophanelioglu C, 13 15 Altunizade, Uskudar, Istanbul 81190 Turkey
    BMC Cancer 5:10. 2005
  2. ncbi Concurrent chemoradiotherapy with low dose weekly gemcitabine in stage III non-small cell lung cancer
    Ufuk Abacioglu
    Department of Radiation Oncology, Marmara University Medical School Hospital, Istanbul, Turkey
    BMC Cancer 5:71. 2005
  3. ncbi Cyclosporin A and imipenem associated seizure activity in allogeneic bone marrow transplantation patients
    N S Turhal
    Marmara University, Department of Internal Medicine, Division of Oncology, Istanbul, Turkey
    J Chemother 11:410-3. 1999
  4. ncbi ERCC1 is not expressed in hepatocellular cancer: A turkish oncology group, gastrointestinal oncology subgroup study
    N S Turhal
    Marmara University School of Medicine, Department of Medical Oncology, Istanbul, Turkey
    J BUON 15:794-6. 2010
  5. ncbi 99m-Tc-MDP-Scintimammography in the evaluation of breast masses or tumor angiogenesis
    Nazim S Turhal
    Department of Internal Medicine, Division of Oncology, Marmara University Hospital, Turkey
    Anticancer Res 24:1999-2006. 2004
  6. ncbi Patient satisfaction in the outpatients' chemotherapy unit of Marmara University, Istanbul, Turkey: a staff survey
    Nazim S Turhal
    Marmara University, Department of Internal Medicine, Division of Oncology, Istanbul, Turkey
    BMC Cancer 2:30. 2002
  7. ncbi Efficacy of treatment to relieve mucositis-induced discomfort
    N S Turhal
    Department of Medicine, Marmara University Hospital, Istanbul, Turkey
    Support Care Cancer 8:55-8. 2000
  8. ncbi Prolonged interval in prophylactic heparin flushing for maintenance of subcutaneous implanted port care in patients with cancer
    U Kefeli
    Department of Internal Medicine, Marmara University Medical School, Istanbul, Turkey
    Eur J Cancer Care (Engl) 18:191-4. 2009
  9. ncbi Impact of body mass index on cancer development
    P Fulden Yumuk
    Department of Internal Medicine, Division of Medical Oncology, Marmara University Medical School, Istanbul, Turkey
    J BUON 13:55-9. 2008
  10. ncbi A case of Kikuchi-Fujimoto disease misdiagnosed as Hodgkin's lymphoma: the importance of second opinion
    F Dane
    Division of Medical Oncology, Department of Pathology, Marmara University School Medicine, Istanbul, Turkey
    J BUON 14:309-11. 2009

Collaborators

Detail Information

Publications17

  1. ncbi Results of paclitaxel (day 1 and 8) and carboplatin given on every three weeks in advanced (stage III-IV) non-small cell lung cancer
    Perran F Yumuk
    Division of Medical Oncology, Marmara University Hospital, Tophanelioglu C, 13 15 Altunizade, Uskudar, Istanbul 81190 Turkey
    BMC Cancer 5:10. 2005
    ..We retrospectively reviewed the data of 51 consecutive patients receiving C and day 1 and 8 P chemotherapy (CT) regimen in advanced stage NSCLC to evaluate the efficacy and toxicity...
  2. ncbi Concurrent chemoradiotherapy with low dose weekly gemcitabine in stage III non-small cell lung cancer
    Ufuk Abacioglu
    Department of Radiation Oncology, Marmara University Medical School Hospital, Istanbul, Turkey
    BMC Cancer 5:71. 2005
    ..Twenty-two consecutive patients were treated with concurrent CRT to demonstrate the tolerability and efficacy of low dose G given weekly as radiosensitizer in stage III NSCLC...
  3. ncbi Cyclosporin A and imipenem associated seizure activity in allogeneic bone marrow transplantation patients
    N S Turhal
    Marmara University, Department of Internal Medicine, Division of Oncology, Istanbul, Turkey
    J Chemother 11:410-3. 1999
    ....
  4. ncbi ERCC1 is not expressed in hepatocellular cancer: A turkish oncology group, gastrointestinal oncology subgroup study
    N S Turhal
    Marmara University School of Medicine, Department of Medical Oncology, Istanbul, Turkey
    J BUON 15:794-6. 2010
    ..Expression of ERCC1 in HCC is not known. In this study we aimed to find out whether a subset of HCC patients can be identified to benefit from cisplatin...
  5. ncbi 99m-Tc-MDP-Scintimammography in the evaluation of breast masses or tumor angiogenesis
    Nazim S Turhal
    Department of Internal Medicine, Division of Oncology, Marmara University Hospital, Turkey
    Anticancer Res 24:1999-2006. 2004
    ..We studied the correlation between MDP uptake and VEGF and compared the diagnostic accuracy of mammography versus MDP-scintimammography (MDP-S)...
  6. ncbi Patient satisfaction in the outpatients' chemotherapy unit of Marmara University, Istanbul, Turkey: a staff survey
    Nazim S Turhal
    Marmara University, Department of Internal Medicine, Division of Oncology, Istanbul, Turkey
    BMC Cancer 2:30. 2002
    ..We conducted a survey to find out how patients feel about the care they receive in the outpatient chemotherapy unit of Marmara University Hospital...
  7. ncbi Efficacy of treatment to relieve mucositis-induced discomfort
    N S Turhal
    Department of Medicine, Marmara University Hospital, Istanbul, Turkey
    Support Care Cancer 8:55-8. 2000
    ..91 (range 0-2.7). These results suggests that this three-drug mouthwash provides effective symptomatic relief in patients with chemotherapy-induced mucositis...
  8. ncbi Prolonged interval in prophylactic heparin flushing for maintenance of subcutaneous implanted port care in patients with cancer
    U Kefeli
    Department of Internal Medicine, Marmara University Medical School, Istanbul, Turkey
    Eur J Cancer Care (Engl) 18:191-4. 2009
    ..Prophylactic flushing of central venous ports with 1000 U of heparin in every 6 weeks might be a safe, easy, cheaper, comfortable and effective alternative to standard dose and schedule for preventing thrombosis and infections...
  9. ncbi Impact of body mass index on cancer development
    P Fulden Yumuk
    Department of Internal Medicine, Division of Medical Oncology, Marmara University Medical School, Istanbul, Turkey
    J BUON 13:55-9. 2008
    ..To determine the impact of body mass index (BMI) on cancer in a hospital-based Turkish population...
  10. ncbi A case of Kikuchi-Fujimoto disease misdiagnosed as Hodgkin's lymphoma: the importance of second opinion
    F Dane
    Division of Medical Oncology, Department of Pathology, Marmara University School Medicine, Istanbul, Turkey
    J BUON 14:309-11. 2009
    ..Ultimately her diagnosis was corrected as KFD after second opinion of the pathology specimens. We herein provide a brief review about KFD and the importance of second opinion of the pathology specimens...
  11. ncbi Outcome of rectal and sigmoid carcinoma patients receiving adjuvant chemoradiotherapy in Marmara University Hospital
    P F Yumuk
    Division of Medical Oncology, Marmara University Medical School Hospital, Tophanelioglu C 13 15, Altunizade, Uskudar, 81190 Istanbul, Turkey
    J Chemother 15:603-6. 2003
    ..Protracted short-term infusion of 5-fluorouracil during pelvic irradiation is a safe treatment modality. Further studies are needed to improve the local control of high-risk rectal and sigmoid carcinomas...
  12. ncbi Toxicity and feasibility analysis for cisplatin-based concomitant chemoradiotherapy in locally advanced nasopharyngeal carcinoma
    B M Atasoy
    Department of Radiation Oncology, Division of Medical Oncology, Marmara University Medical School, Istanbul, Turkey
    J BUON 13:43-50. 2008
    ..To assess the side effects of cisplatin-based concurrent chemoradiotherapy (CRT) for locally advanced nasopharyngeal carcinoma (NPC)...
  13. ncbi Synchronous renal cell carcinoma and multiple myeloma: report of two cases and review of the literature
    M A Ozturk
    Department of Internal Medicine, Marmara University School of Medicine, Istanbul, Turkey
    J BUON 14:511-4. 2009
    ....
  14. ncbi Cancer-related false knowledge in relatives of cancer patients and the general public
    N S Turhal
    Marmara University, School of Medicine, Department of Medical Oncology, Istanbul, Turkey
    J BUON 15:310-3. 2010
    ....
  15. ncbi Anxiety and depression in Turkish breast cancer patients
    N S Turhal
    Marmara University, School of Medicine, Department of Medical Oncology, Istanbul, Turkey
    J BUON 15:720-5. 2010
    ..we investigated the anxiety and depression rates in breast cancer patients (BCPs) and compared their rates with a group of unemployed women attending courses at a local government agency to increase their chances for employment...
  16. ncbi HPV DNA frequency and subset analysis in human breast cancer patients' normal and tumoral tissue samples
    M Gumus
    Department of Internal Medicine, Division of Medical Oncology, Dr Lutfi Kirdar Kartal Research and Training Hospital, Istanbul, Turkey
    J Exp Clin Cancer Res 25:515-21. 2006
    ..HPV DNA was significantly associated with breast tumor tissue compared to normal breast tissue. Additional studies looking at HPV and HPV subtypes are needed to clarify the etiological role of the HPV in breast cancer...
  17. ncbi D-dimer--can it be a marker for malignant gastric lesions?
    Mehmet Aliustaoglu
    Acta Oncol 43:770-1. 2004